Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Easterbrook

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|April 26, 2000
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinicP J Easterbrook, L M Yu, E Goetghebeur, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimensP J Easterbrook, R Newson, N Ives, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Incidence and risk factors for the development of indinavir-associated renal complicationsJ S Herman, N J Ives, M Nelson, et al.
HIV Medicine|April 6, 2005
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south LondonA E Boyd, S Murad, S O'shea, et al.
Clinical Science (London, England : 1979)|December 10, 1999
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infectionD A Price, C A O'callaghan, J A Whelan, et al.
International Journal of STD & AIDS|October 9, 1998
Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patientsF B Hannon, P J Easterbrook, S Padley, et al.
The Journal of Infectious Diseases|September 9, 1999
Chemokine receptor polymorphisms and human immunodeficiency virus disease progressionP J Easterbrook, T Rostron, N Ives, et al.
AIDS (London, England)|February 1, 1997
Long-term survival in patients with advanced immunodeficiencyG Chêne, P J Easterbrook, E Juszczak, et al.
Clinical and Experimental Immunology|November 25, 2003
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjectsM J Boaz, A Waters, S Murad, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|April 26, 2000
Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinicP J Easterbrook, L M Yu, E Goetghebeur, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2001
Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimensP J Easterbrook, R Newson, N Ives, et al.
The Journal of Antimicrobial Chemotherapy|September 5, 2001
Incidence and risk factors for the development of indinavir-associated renal complicationsJ S Herman, N J Ives, M Nelson, et al.
HIV Medicine|April 6, 2005
Ethnic differences in stage of presentation of adults newly diagnosed with HIV-1 infection in south LondonA E Boyd, S Murad, S O'shea, et al.
Clinical Science (London, England : 1979)|December 10, 1999
Cytotoxic T lymphocytes and viral evolution in primary HIV-1 infectionD A Price, C A O'callaghan, J A Whelan, et al.
International Journal of STD & AIDS|October 9, 1998
Bronchopulmonary Kaposi's sarcoma in 106 HIV-1 infected patientsF B Hannon, P J Easterbrook, S Padley, et al.
The Journal of Infectious Diseases|September 9, 1999
Chemokine receptor polymorphisms and human immunodeficiency virus disease progressionP J Easterbrook, T Rostron, N Ives, et al.
AIDS (London, England)|February 1, 1997
Long-term survival in patients with advanced immunodeficiencyG Chêne, P J Easterbrook, E Juszczak, et al.
Clinical and Experimental Immunology|November 25, 2003
CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjectsM J Boaz, A Waters, S Murad, et al.
HIV Medicine|December 12, 2001
How generalizable are the results of large randomized controlled trials of antiretroviral therapy?D A Moore, R L Goodall, N J Ives, et al.
Pageof 6